According to Advaxis's latest financial reports the company's current revenue (TTM) is $0.13 M. In 2021 the company made a revenue of $3.5 M a decrease over the years 2020 revenue that were of $3.7 M.The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.
Year | Revenue | Change |
---|---|---|
2023 (TTM) | $0.13 M | |
2021 | $3.5 M | -5.45% |
2020 | $3.7 M | 58.87% |
2019 | $2.33 M |
Company | Revenue | Revenue differencediff. | Country |
---|---|---|---|
Genocea Biosciences
GNCA | $1.91 M | 1,284.78% | ๐บ๐ธ USA |
Inovio Pharmaceuticals INO | $0.83 M | 502.91% | ๐บ๐ธ USA |
Heska Corporation
HSKA | $0.25 B | 184,601.45% | ๐บ๐ธ USA |